# PetVivo Holdings, Inc. (PETV) · Edgar & Edgarette company card

> PetVivo Holdings (PETV) grew revenue 0.8% in FY2026 to $1 million, operating margin -794% against a 1.2% median for surgical & medical instruments & apparatus, equity 61.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1512922 · fiscal year ended 2026-03-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PETV) · [JSON](https://www.pops4.com/boards/company/PETV.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1M |
| Revenue growth, 1 year | 0.8% |
| Revenue growth per year | 77.3% |
| Operating margin | -793.9% (prior year -711.3%) |
| Net margin | -917.4% |
| Operating cash flow | −$6M |
| Capital spending | $7,734 |
| Free cash flow | −$6M |
| Cash | — |
| Long-term debt | — |
| Total assets | $4M |
| Total equity | $2M |
| Equity ÷ assets | 61.5% |
| Return on equity | -476.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -107.5 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Beneish M: -7.38 (below the −1.78 line)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed auditor change in the last 12 months; operating cash flow was negative; operating loss: a margin of -793.9% in FY2026; revenue is hard to predict: its 80% range is ±73%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $1.1M (FY2026). Experience: revenue up 0.8% on the year, up 77.3% a year over 4 years; operating margin -793.9%, down from -711.3%. Soundness: equity 61.5% of assets, return on equity -476.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $468K and $2.9M next year (method v4.1: its own 4-year record of growth weighed at 50% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $413K to $3.4M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -793.9% against a 1.2% median; growth 0.8% against 11.6%.

Range logged 2026-09-24, receipt 17f5fdd8e00b755d, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 4.01 Auditor change: 1, latest 2026-07-27 ([filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226034762/0001493152-26-034762-index.htm))
- Item 5.02 Director or officer change: 4, latest 2026-09-22 ([filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226043639/0001493152-26-043639-index.htm))

## Recent filings

- 8-K · filed 2026-09-22 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226043639/0001493152-26-043639-index.htm)
- 8-K · filed 2026-09-22 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226043641/0001493152-26-043641-index.htm)
- 8-K · filed 2026-08-20 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226039397/0001493152-26-039397-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226038477/0001493152-26-038477-index.htm)
- 8-K · filed 2026-07-29 · 1.02 Termination of a Material Definitive Agreement; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226035053/0001493152-26-035053-index.htm)
- 8-K · filed 2026-07-27 · 4.01 Changes in Registrant's Certifying Accountant; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1512922/000149315226034762/0001493152-26-034762-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001512922.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1512922

## Cite

POPS4, Edgar & Edgarette: PetVivo Holdings, Inc. (PETV) company card, from the company's own SEC filings, accessed 2026-11-07, https://www.pops4.com/boards/company/PETV. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.